![Bruce Keyt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce Keyt
Keine laufenden Positionen mehr
Profil
Bruce A. Keyt's former jobs include being a Director-Pharmacology at Millennium Pharmaceuticals, Inc. from 1998 to 2001, a Senior Scientist at Genentech, Inc. from 1982 to 1998, a Vice President-Preclinical Development at Abgenix, Inc. from 2001 to 2005, a Chief Technology Officer at Trellis Bioscience, Inc. from 2007 to 2010, and a Vice President-Research & Development at Abmaxis, Inc. from 2005 to 2006.
He also worked as a Vice President-Discovery Research Consultant at Aridis Pharmaceuticals, Inc. Additionally, Dr. Keyt is currently serving as the Chief Scientific Officer at IGM Biosciences, Inc. since 2012.
Dr. Keyt obtained his undergraduate degree from Washington University in St. Louis and his doctorate degree from Tufts University School of Medicine.
Ehemalige bekannte Positionen von Bruce Keyt
| Unternehmen | Position | Ende |
|---|---|---|
| IGM BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2024 |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2010 |
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Corporate Officer/Principal | 01.01.2005 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Bruce Keyt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Aridis Pharmaceuticals, Inc.
 Aridis Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for infectious diseases | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
